The 39th Congress of Société Internationale d’Urologie, Athens, Greece, 16/10/2019-20/10/2019 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 28 European CME credits!
We are pleased to announce that the Société Internationale d'Urologie Congress has been granted SFEE compliance. For more information, please click here.
The SIU is dedicated to advancing urology worldwide and bringing urologists together.
Find out how we take innovative approaches to education, networking, research, collaboration and philanthropy in this 90-second video. See for yourself what the SIU is all about!
Check out some our Congress highlights in the 2019 SIU uMAG!
The 39th Congress of the Société Internationale d'Urologie is compliant with the provisions of the MedTech Europe Code of Ethical Business Practice. For more information, please click HERE
The Taiwan Urological Association (TUA) will hold its 6th annual International section of Taiwan Urological Association Conference (ISTUA), which is taking place in Taichung, Taiwan on August 17th, 2019. TUA welcomes original abstracts from investigators in the urology community. Submission will be accepted from academic institutions, teaching and community hospitals, or industry. Both TUA members and non-TUA members may participate.
Submitted research may fall into any of the areas below:
The deadline for abstract submission is March 31th, 2019, 11:59 PM Taiwan Time. First authors can expect to be notified of their abstract by mid-May 2019.
Abstracts will be evaluated using a peer review process. Urology research faculty from TUA members will serve as peer reviewers to approve research to display at the Podium or Poster Session.
The abstract should include title, authors, institution, purpose, materials and methods, results and conclusion
Oral presentation (Podium) – 7 min presentation and 2 min discussion
Poster presentation – poster size: 90 cm width and 180 cm length
ICS 2019 will offer multidisciplinary sessions for delegates in urology, gynaecology, colorectal surgery, physiotherapy, nursing, medical, and basic science disciplines. To ensure maximum interactivity and take-home value we have included various session formats:
You can also be part of this world class programme - submit your abstract by April 1, to present your research at the premium continence and pelvic floor dysfunction meeting!
For more information, visit the ICS 2019 website: https://www.ics.org/2019
Calling all urologists a interested in current trends in the diagnosis and treatment of lower urinary tract symptoms (LUTS) and erectile dysfunction (ED). The upcoming SIU B2B-LUTS & ED Meeting in Greece will cover the hottest topics in LUTS and ED.
If you work or have a keen interest in these areas, this event is for you. You are guaranteed to learn from the distinguished international experts who will be sharing their knowledge.
Click here for more information and to register. Hurry up, places are limited!
Tremendous advancements have been made in diagnosis and treatment with the recent FDA approval of a targeted therapy for metastatic bladder cancer with FGFR3 or FGFR2 genetic alterations, two combination immunotherapy-targeted therapies as first-line treatment for advanced RCC, as well as advances in diagnostics and immunotherapy research for prostate cancer
Take advantage of this highly anticipated event and immerse yourself in the evolving landscape of urological cancer care.
For more information and to register, click here. Space is limited!
22nd Congress of the European Society for Sexual Medicine
Prague, Czech Republic | 23rd to 25th January 2020
For more information, please click here.